Correlation Between NorAm Drilling and Vertex Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both NorAm Drilling and Vertex Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining NorAm Drilling and Vertex Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between NorAm Drilling AS and Vertex Pharmaceuticals Incorporated, you can compare the effects of market volatilities on NorAm Drilling and Vertex Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in NorAm Drilling with a short position of Vertex Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of NorAm Drilling and Vertex Pharmaceuticals.

Diversification Opportunities for NorAm Drilling and Vertex Pharmaceuticals

-0.41

Correlation Coefficient

NorAm Drilling  Vertex Pharmaceuticals

Very good diversification

The 3 months correlation between NorAm and Vertex is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding NorAm Drilling AS and Vertex Pharmaceuticals Incorpo in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vertex Pharmaceuticals and NorAm Drilling is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on NorAm Drilling AS are associated (or correlated) with Vertex Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vertex Pharmaceuticals has no effect on the direction of NorAm Drilling i.e., NorAm Drilling and Vertex Pharmaceuticals go up and down completely randomly.

Pair Corralation between NorAm Drilling and Vertex Pharmaceuticals

Assuming the 90 days horizon NorAm Drilling AS is expected to under-perform the Vertex Pharmaceuticals. In addition to that, NorAm Drilling is 2.17 times more volatile than Vertex Pharmaceuticals Incorporated. It trades about -0.06 of its total potential returns per unit of risk. Vertex Pharmaceuticals Incorporated is currently generating about 0.04 per unit of volatility. If you would invest  42,645  in Vertex Pharmaceuticals Incorporated on September 20, 2024 and sell it today you would earn a total of  1,835  from holding Vertex Pharmaceuticals Incorporated or generate 4.3% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	98.46%
Values	Daily Returns

NorAm Drilling AS  vs.  Vertex Pharmaceuticals Incorpo

NorAm Drilling AS

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days NorAm Drilling AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Vertex Pharmaceuticals

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Vertex Pharmaceuticals Incorporated are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable basic indicators, Vertex Pharmaceuticals is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with NorAm Drilling and Vertex Pharmaceuticals

The main advantage of trading using opposite NorAm Drilling and Vertex Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if NorAm Drilling position performs unexpectedly, Vertex Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vertex Pharmaceuticals will offset losses from the drop in Vertex Pharmaceuticals' long position.

The idea behind NorAm Drilling AS and Vertex Pharmaceuticals Incorporated pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.